SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-23-010392
Filing Date
2023-04-03
Accepted
2023-04-03 16:13:46
Documents
10
Period of Report
2023-04-03

Document Format Files

Seq Description Document Type Size
1 PRE 14A esperion-preliminary2022pr.htm PRE 14A 867743
2 blookersigv2.jpg GRAPHIC 5422
3 espe_rmxrgbxfcxpos002.jpg GRAPHIC 44145
4 image.jpg GRAPHIC 74040
5 image1.jpg GRAPHIC 15411
6 image2.jpg GRAPHIC 60575
7 image3.jpg GRAPHIC 112279
8 image4.jpg GRAPHIC 102705
9 image5.jpg GRAPHIC 14978
10 sheldonsignature.jpg GRAPHIC 20271
  Complete submission text file 0001628280-23-010392.txt   1487229
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35986 | Film No.: 23792763
SIC: 2834 Pharmaceutical Preparations